(KRP) Kimbell Royalty Partners - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US49435R1023
Mineral, Royalty, Oil, Gas
Dividends
| Dividend Yield | 12.79% |
| Yield on Cost 5y | 29.14% |
| Yield CAGR 5y | 19.09% |
| Payout Consistency | 92.2% |
| Payout Ratio | 2.5% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 23.1% |
| Value at Risk 5%th | 40.2% |
| Relative Tail Risk | 5.80% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.45 |
| Alpha | -24.12 |
| CAGR/Max DD | 0.10 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.474 |
| Beta | 0.751 |
| Beta Downside | 1.141 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.58% |
| Mean DD | 6.33% |
| Median DD | 5.11% |
Description: KRP Kimbell Royalty Partners November 11, 2025
Kimbell Royalty Partners LP (NYSE: KRP) is a Texas-based royalty and mineral-interest firm that acquires and holds working interests in U.S. oil and natural-gas properties. Founded in 1998, the partnership generates cash flow primarily through royalty streams rather than operating costs, positioning it as a pure exposure play to upstream commodity prices.
Key metrics as of the latest filing (2023-24): a trailing twelve-month distribution of $2.35 per unit, yielding roughly 6.5% based on the current share price; net cash flow of about $460 million, of which >90% is covered by operating cash; and a net asset value (NAV) of roughly $21 per unit, indicating modest upside potential if commodity prices rise. The partnership’s performance is tightly linked to U.S. natural-gas price dynamics, regional production growth in the Permian and Eagle Ford basins, and the broader LNG export outlook, which together drive royalty revenue trends.
For a deeper, data-driven look at KRP’s valuation assumptions and scenario analysis, you may find ValueRay’s platform useful for extending your research.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (36.6m TTM) > 0 and > 6% of Revenue (6% = 19.7m TTM) |
| FCFTA 0.02 (>2.0%) and ΔFCFTA -19.03pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 21.92% (prev 22.95%; Δ -1.03pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.20 (>3.0%) and CFO 245.8m > Net Income 36.6m (YES >=105%, WARN >=100%) |
| Net Debt (413.0m) to EBITDA (155.1m) ratio: 2.66 <= 3.0 (WARN <= 3.5) |
| Current Ratio 5.39 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (118.2m) change vs 12m ago 1.55% (target <= -2.0% for YES) |
| Gross Margin 74.55% (prev 50.15%; Δ 24.40pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 26.60% (prev 26.70%; Δ -0.10pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.04 (EBITDA TTM 155.1m / Interest Expense TTM 31.3m) >= 6 (WARN >= 3) |
ValueRay F-Score (Strict, 0-100) 50.47
| 1. Piotroski 4.50pt |
| 2. FCF Yield 1.22% |
| 3. FCF Margin 6.85% |
| 4. Debt/Equity 0.65 |
| 5. Debt/Ebitda 2.66 |
| 6. ROIC - WACC (= -3.92)% |
| 7. RoE 4.71% |
| 8. Rev. Trend 64.22% |
| 9. EPS Trend -54.36% |
What is the price of KRP shares?
As of December 04, 2025, the stock is trading at USD 12.69 with a total of 537,432 shares traded.
Over the past week, the price has changed by +4.27%, over one month by -0.98%, over three months by -5.24% and over the past year by -11.68%.
Over the past week, the price has changed by +4.27%, over one month by -0.98%, over three months by -5.24% and over the past year by -11.68%.
Is KRP a buy, sell or hold?
Kimbell Royalty Partners has received a consensus analysts rating of 3.83.
Therefore, it is recommended to buy KRP.
- Strong Buy: 3
- Buy: 0
- Hold: 2
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the KRP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 17.2 | 35.5% |
| Analysts Target Price | 17.2 | 35.5% |
| ValueRay Target Price | 14.5 | 13.9% |
KRP Fundamental Data Overview November 25, 2025
Market Cap USD = 1.43b (1.43b USD * 1.0 USD.USD)
P/E Forward = 9.1158
P/S = 4.5307
P/B = 1.767
Beta = 0.302
Revenue TTM = 328.3m USD
EBIT TTM = 32.7m USD
EBITDA TTM = 155.1m USD
Long Term Debt = 448.5m USD (from longTermDebt, last quarter)
Short Term Debt = 489.1k USD (from shortTermDebt, last fiscal year)
Debt = 453.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 413.0m USD (from netDebt column, last quarter)
Enterprise Value = 1.84b USD (1.43b + Debt 453.0m - CCE 40.0m)
Interest Coverage Ratio = 1.04 (Ebit TTM 32.7m / Interest Expense TTM 31.3m)
FCF Yield = 1.22% (FCF TTM 22.5m / Enterprise Value 1.84b)
FCF Margin = 6.85% (FCF TTM 22.5m / Revenue TTM 328.3m)
Net Margin = 11.14% (Net Income TTM 36.6m / Revenue TTM 328.3m)
Gross Margin = 74.55% ((Revenue TTM 328.3m - Cost of Revenue TTM 83.5m) / Revenue TTM)
Gross Margin QoQ = 93.04% (prev 93.40%)
Tobins Q-Ratio = 1.47 (Enterprise Value 1.84b / Total Assets 1.25b)
Interest Expense / Debt = 2.16% (Interest Expense 9.78m / Debt 453.0m)
Taxrate = -17.08% (negative due to tax credits) (-3.26m / 19.1m)
NOPAT = 38.3m (EBIT 32.7m * (1 - -17.08%)) [negative tax rate / tax credits]
Current Ratio = 5.39 (Total Current Assets 88.4m / Total Current Liabilities 16.4m)
Debt / Equity = 0.65 (Debt 453.0m / totalStockholderEquity, last quarter 700.4m)
Debt / EBITDA = 2.66 (Net Debt 413.0m / EBITDA 155.1m)
Debt / FCF = 18.36 (Net Debt 413.0m / FCF TTM 22.5m)
Total Stockholder Equity = 776.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.92% (Net Income 36.6m / Total Assets 1.25b)
RoE = 4.71% (Net Income TTM 36.6m / Total Stockholder Equity 776.7m)
RoCE = 2.67% (EBIT 32.7m / Capital Employed (Equity 776.7m + L.T.Debt 448.5m))
RoIC = 3.36% (NOPAT 38.3m / Invested Capital 1.14b)
WACC = 7.28% (E(1.43b)/V(1.88b) * Re(8.78%) + D(453.0m)/V(1.88b) * Rd(2.16%) * (1-Tc(-0.17)))
Discount Rate = 8.78% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.21%
[DCF Debug] Terminal Value 67.19% ; FCFE base≈114.7m ; Y1≈75.3m ; Y5≈34.4m
Fair Price DCF = 6.42 (DCF Value 599.5m / Shares Outstanding 93.4m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -54.36 | EPS CAGR: -17.62% | SUE: 0.64 | # QB: 0
Revenue Correlation: 64.22 | Revenue CAGR: 12.09% | SUE: 0.10 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.16 | Chg30d=-0.030 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=0.67 | Chg30d=-0.010 | Revisions Net=+0 | Growth EPS=-8.9% | Growth Revenue=+0.9%
P/E Forward = 9.1158
P/S = 4.5307
P/B = 1.767
Beta = 0.302
Revenue TTM = 328.3m USD
EBIT TTM = 32.7m USD
EBITDA TTM = 155.1m USD
Long Term Debt = 448.5m USD (from longTermDebt, last quarter)
Short Term Debt = 489.1k USD (from shortTermDebt, last fiscal year)
Debt = 453.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 413.0m USD (from netDebt column, last quarter)
Enterprise Value = 1.84b USD (1.43b + Debt 453.0m - CCE 40.0m)
Interest Coverage Ratio = 1.04 (Ebit TTM 32.7m / Interest Expense TTM 31.3m)
FCF Yield = 1.22% (FCF TTM 22.5m / Enterprise Value 1.84b)
FCF Margin = 6.85% (FCF TTM 22.5m / Revenue TTM 328.3m)
Net Margin = 11.14% (Net Income TTM 36.6m / Revenue TTM 328.3m)
Gross Margin = 74.55% ((Revenue TTM 328.3m - Cost of Revenue TTM 83.5m) / Revenue TTM)
Gross Margin QoQ = 93.04% (prev 93.40%)
Tobins Q-Ratio = 1.47 (Enterprise Value 1.84b / Total Assets 1.25b)
Interest Expense / Debt = 2.16% (Interest Expense 9.78m / Debt 453.0m)
Taxrate = -17.08% (negative due to tax credits) (-3.26m / 19.1m)
NOPAT = 38.3m (EBIT 32.7m * (1 - -17.08%)) [negative tax rate / tax credits]
Current Ratio = 5.39 (Total Current Assets 88.4m / Total Current Liabilities 16.4m)
Debt / Equity = 0.65 (Debt 453.0m / totalStockholderEquity, last quarter 700.4m)
Debt / EBITDA = 2.66 (Net Debt 413.0m / EBITDA 155.1m)
Debt / FCF = 18.36 (Net Debt 413.0m / FCF TTM 22.5m)
Total Stockholder Equity = 776.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.92% (Net Income 36.6m / Total Assets 1.25b)
RoE = 4.71% (Net Income TTM 36.6m / Total Stockholder Equity 776.7m)
RoCE = 2.67% (EBIT 32.7m / Capital Employed (Equity 776.7m + L.T.Debt 448.5m))
RoIC = 3.36% (NOPAT 38.3m / Invested Capital 1.14b)
WACC = 7.28% (E(1.43b)/V(1.88b) * Re(8.78%) + D(453.0m)/V(1.88b) * Rd(2.16%) * (1-Tc(-0.17)))
Discount Rate = 8.78% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.21%
[DCF Debug] Terminal Value 67.19% ; FCFE base≈114.7m ; Y1≈75.3m ; Y5≈34.4m
Fair Price DCF = 6.42 (DCF Value 599.5m / Shares Outstanding 93.4m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -54.36 | EPS CAGR: -17.62% | SUE: 0.64 | # QB: 0
Revenue Correlation: 64.22 | Revenue CAGR: 12.09% | SUE: 0.10 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.16 | Chg30d=-0.030 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=0.67 | Chg30d=-0.010 | Revisions Net=+0 | Growth EPS=-8.9% | Growth Revenue=+0.9%
Additional Sources for KRP Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle